CN103301170A - Anoplophora chinensis larva medicine - Google Patents
Anoplophora chinensis larva medicine Download PDFInfo
- Publication number
- CN103301170A CN103301170A CN2013101858443A CN201310185844A CN103301170A CN 103301170 A CN103301170 A CN 103301170A CN 2013101858443 A CN2013101858443 A CN 2013101858443A CN 201310185844 A CN201310185844 A CN 201310185844A CN 103301170 A CN103301170 A CN 103301170A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- meridian
- anoplophora chinensis
- eggs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an anoplophora chinensis larva medicine. The anoplophora chinensis larva medicine is prepared from medicinal raw materials which comprise the following medicines in parts by weight: 2 to 8 anoplophora chinensis larvae, 5 to 30 parts of sesame oil, 5 to 30 eggs and 30 to 100 parts of water. A decocting method comprises the following steps: putting the four anoplophora chinensis larvae into a decocting pot; pouring into 5 parts of the sesame oil, breaking the six eggs and adding 80 parts of the water; decocting to form 10 parts; and filtering impurities, thereby being suitable for oral administration. The medicine has the exact and reliable effects for treating tumors, hypertension, cerebral thrombosis, myocardial infarction, rheumatic arthritis and apoplexy.
Description
Technical field
The invention belongs to the pharmaceutical composition take Chinese medicine as preparation of raw material, particularly the Chinese medicine composition for the treatment of tumor, hypertension, cerebral thrombosis, myocardial infarction, rheumatic arthritis, apoplexy.
Background technology
Tumor (Tumor) be body under various carcinogenic factor effects, some cells of local organization lose normal regulation to its growth at gene level, cause its clonal abnormality hypertrophy and the neoplasm that forms.The cause of cancer at first is equilibrium between yin and yang in the human body, and histiocyte is under different carcinogenic factor long terms, and cell mutation causes, it be mainly manifested in the unusual and excessive hypertrophy of histiocyte.Cancerous tissue also is the part of human body in fact, and only at this imbalance between YIN and YANG of people, generation-inhibition in five elements is taken advantage of and insulted under the prerequisite that changes, and the immune monitoring system of human body just can lose monitoring to it, develops as one pleases.In the course of time, cancerous cell is bred day by day, and tumor troop grows stronger day by day, and corrodes at last normal surrounding tissue, and lot of energy and nutrition affect the normal physiological metabolism of human body, causes body depleted gradually, finally causes death
According to classic of TCM record and inventor observational study for many years, cancerous tissue also is the part of human body, and only at this imbalance between YIN and YANG of people, generation-inhibition in five elements is taken advantage of and insulted under the prerequisite that changes, and the immune monitoring system of human body just can lose monitoring to it, develops as one pleases.In the course of time, cancerous cell is bred day by day, and tumor troop grows stronger day by day, and corrodes at last normal surrounding tissue, and lot of energy and nutrition affect the normal physiological metabolism of human body, causes body depleted gradually, finally causes death.
The meridian worm is a kind of parasite that is about 2,3 centimetres in the trees that are deep in the mountains of growth, and it has certain curative effect among the people to the treatment various diseases.
Summary of the invention
For the problems referred to above, the objective of the invention is to propose a kind of meridian worm medicine, it easily makes, easy to use, treatment tumor, hypertension, cerebral thrombosis, myocardial infarction, rheumatic arthritis, apoplexy have definite reliably curative effect.
The objective of the invention is to be achieved through the following technical solutions: meridian worm medicine, it is characterized in that, the pharmacodynamic raw materials of making it comprises the medicine of following weight proportioning: 2~8 of meridian worms, 5~30 parts of Oleum sesami, 5~30 pieces in egg, 30~100 parts in water.Decocting method: get 4 of meridian worms, put into frying pan, pour 5 portions of Oleum sesami into, squeeze into 6 pieces of eggs, add 80 parts of decoctings and boil 10 parts, filter out impurities, take and get final product.
The present invention adopts 2~8 of meridian worms, 5~30 parts of Oleum sesami, 5~30 pieces in egg, 30~100 parts in water.Decocting method: get 4 of meridian worms, put into frying pan, pour 5 portions of Oleum sesami into, squeeze into 6 pieces of eggs, add 80 parts of decoctings and boil 10 parts, filter out impurities, take and get final product, treatment tumor, hypertension, cerebral thrombosis, myocardial infarction, rheumatic arthritis, apoplexy are had definite reliably curative effect.
The specific embodiment
The present invention is described further below in conjunction with drawings and Examples:
Embodiment: meridian worm medicine, the pharmacodynamic raw materials of making it comprises the medicine of following weight proportioning: 2~8 of meridian worms, 5~30 parts of Oleum sesami, 5~30 pieces in egg, 30~100 parts in water.Decocting method: get 4 of meridian worms, put into frying pan, pour 5 portions of Oleum sesami into, squeeze into 6 pieces of eggs, add 80 parts of decoctings and boil 10 parts, filter out impurities, take and get final product.
Experimental example is used Drug therapy tumor 104 routine clinical efficacies of the present invention and is summed up
The inventor uses several 80 examples of Drug therapy tumor patient of the present invention in many decades, obtain good result.Now select 104 complete routine final reports of term calendar year 2001 to 2008 interocclusal record as follows.
(1) physical data
This is organized in 104 examples, male 76 examples, women 28 examples; 9~76 years old age, the median age 51 years old; All cases all are diagnosed as tumor according to medical history, focal lesion feature, whole body performance, and 1 of the equal medication of all cases is observed more than 3 months after treatment finishes more than the course for the treatment of.Observe 3 months persons of less than after 1 course for the treatment of under medication, the drug withdrawal and do not include this group statistics in.This group 104 its Staging of course of disease of example and Clinical typing are listed as follows.
This group of table 1 104 routine tumor courses of disease distribute
This group of table 2 104 routine clinical tumor typings
(2) Therapeutic Method
Get 4 of meridian worms, put into frying pan, pour 5 portions of Oleum sesami into, squeeze into 6 pieces of eggs, add 80 parts of decoctings and boil 10 parts, filter out impurities, take and get final product.
(3) therapeutic outcome
Curative effect judging standard:
Cure: focal lesion disappears fully, and without pain, follow-up observation is the nothing recurrence more than 3 months;
Produce effects: focal lesion 80% disappears, and idol has slight pain;
Take a turn for the better: focal lesion number of blocks and area reduce to some extent, but the amount that reduces does not reach 50% of the front focal lesion gross area for the treatment of, and the focus pain alleviates to some extent;
Invalid: focal lesion area and focus pain have no significant change before the treatment.
By above-mentioned curative effect judging standard, this is organized 104 routine oncologic application curative effect of medication of the present invention and analyzes such as table 3.
The 104 routine tumor efficiency analyses of this group of table 3
Table 3 shows, the effective percentage of the various tumor of Drug therapy of the present invention reaches 95.2%, and cure rate reaches 79.8%.Wherein healing person's 83 examples all are three courses for the treatment of of medication.
Claims (2)
1. a meridian worm medicine is characterized in that, the pharmacodynamic raw materials of making it comprises the medicine of following weight proportioning: 2~8 of meridian worms, 5~30 parts of Oleum sesami, 5~30 pieces in egg, 30~100 parts in water.
2. meridian worm medicine according to claim 1 is characterized in that its decocting method: get 4 of meridian worms, put into frying pan, pour 5 portions of Oleum sesami into, squeeze into 6 pieces of eggs, add 80 parts of decoctings and boil 10 parts, filter out impurities, take and get final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101858443A CN103301170A (en) | 2013-05-20 | 2013-05-20 | Anoplophora chinensis larva medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101858443A CN103301170A (en) | 2013-05-20 | 2013-05-20 | Anoplophora chinensis larva medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103301170A true CN103301170A (en) | 2013-09-18 |
Family
ID=49127177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101858443A Pending CN103301170A (en) | 2013-05-20 | 2013-05-20 | Anoplophora chinensis larva medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103301170A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030850A (en) * | 2015-06-18 | 2015-11-11 | 刘河 | Anti-cancer cinobufagin venom toad essential oil |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1579447A (en) * | 2003-08-04 | 2005-02-16 | 金宇 | Cancer prevention and treatment medicine, its preparation and using method |
US20130011499A1 (en) * | 2009-12-10 | 2013-01-10 | Chen-Yu Lee | Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells |
-
2013
- 2013-05-20 CN CN2013101858443A patent/CN103301170A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1579447A (en) * | 2003-08-04 | 2005-02-16 | 金宇 | Cancer prevention and treatment medicine, its preparation and using method |
US20130011499A1 (en) * | 2009-12-10 | 2013-01-10 | Chen-Yu Lee | Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells |
Non-Patent Citations (3)
Title |
---|
朱来顺等: "童子虫治疗鼻咽癌1例", 《安徽中医临床杂志》 * |
王纯义等: "《鸡蛋食疗法》", 31 August 1986, 中医古籍出版社 * |
田志超等: "斗米虫人工培养的初步研究", 《浙江农业科学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030850A (en) * | 2015-06-18 | 2015-11-11 | 刘河 | Anti-cancer cinobufagin venom toad essential oil |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10646534B2 (en) | Formulation, preparation method and use of Chinese herbal medicine composition for soothing liver | |
CN106236927A (en) | A kind of Chinese medicine composition with enhancing immunity and antifatigue effect and preparation method thereof and purposes | |
CN103301170A (en) | Anoplophora chinensis larva medicine | |
CN102462787B (en) | Chinese medicine composition for treating hypertension and improving hyperlipidemia and preparation method of Chinese medicine composition | |
CN102038799B (en) | Application of breast lump-elimination preparation in preparing medicines for treating dysmenorrhea | |
CN103479895A (en) | Heart comforting and brain clearing traditional Chinese medicine composition | |
CN101991757B (en) | Chinese medicinal composition for reinforcing kidney and supporting yang and preparation method thereof | |
CN101327268B (en) | Oral chinese medicine for treating solar urticaria | |
CN104666927A (en) | Traditional Chinese medicine composition and application thereof in regulating human immune functions and/or resisting tumors | |
CN109200108B (en) | Traditional Chinese medicine composition for treating depression and preparation method and application thereof | |
CN104069062B (en) | Hilicidum injection for preventing and treating ischemic cardiovascular and cerebrovascular diseases as well as preparation method and application thereof | |
CN103495044B (en) | Pure traditional Chinese medicine preparation for treating neurosis | |
CN102552481A (en) | Traditional Chinese medicinal composition with effects of smoothing collaterals and lowering blood pressure and preparation method thereof | |
CN104435970B (en) | The composition and preparation method of a kind of kidney and spleen invigorating | |
CN102302734B (en) | Agent for treating insomnia | |
CN104069119B (en) | A kind of application of helicidum and preparation | |
CN104000902B (en) | Medicated wine of a kind of resisting fatigue and its preparation method and application | |
CN103751634B (en) | A kind ofly treat high medicine of spleen and preparation method thereof | |
CN102579618B (en) | Yansheng pills | |
CN104127746A (en) | Traditional Chinese medicinal composition for balancing and nourishing, and preparation method and application thereof | |
CN102671105A (en) | Combined spicebush root traditional Chinese medicine oral liquid for treating chronic gastroenteritis and preparation method thereof | |
CN103127181B (en) | Medicinal composition for treating leucoderma, and preparation method of medicinal preparation thereof | |
CN112245526A (en) | Health-preserving health-care wine containing garter snake as well as preparation method and application thereof | |
CN103933476A (en) | Pharmaceutical composition for treating intercostal neuralgia, and preparation method and application thereof | |
CN118252883A (en) | Traditional Chinese medicine composition for treating ovarian cancer and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Wu Quanding Document name: Notification that Application Deemed to be Withdrawn |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130918 |